secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001837607-25-000059
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma elects Fischer and Carter as Class II directors; ratifies KPMG
-----------------------------------------------------------------------------

- Jost Fischer and Eric Carter elected as Class II directors for three-year terms ending 2028.
- Fischer received 661,774 votes for and 138,295 withheld; Carter 674,894 for and 125,175 withheld.
- KPMG ratified as independent auditor for FY 2025 with 4,956,438 for, 170,672 against, 30,177 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000059/0001837607-25-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000059/aeon-20250613x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-25-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer